Jazz Pharmaceuticals Plans $1 Bln Notes Offering, Concurrent $225 Mln Share Buyback
(RTTNews) - Jazz Pharmaceuticals plc (JAZZ), a biopharmaceutical company, on Wednesday announced plans to offer $1 billion of exchangeable senior notes due 2032 in a private offering.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.